Oral [60]fullerene reduces neuroinflammation to alleviate Parkinson's disease via regulating gut microbiome
Theranostics · 2023
DOI: 10.7150/thno.85711 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2023. Verfasst von Xue Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Beijing National Laboratory for Molecular Sciences, Key Laboratory of Molecular Nanostructure and Nanotechnology, CAS Research/Education Center for E…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Fullerenes, Parkinson Disease, Neuroinflammatory Diseases. Die Arbeit wurde bisher 26-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing National Laboratory for Molecular Sciences, Key Laboratory of Molecular Nanostructure and Nanotechnology, CAS Research/Education Center for Excellence in Molecular Sciences, Institute of Chemistry, Chinese Acade…
- University of Chinese Academy of Sciences, Beijing 100049, China.
- Beijing Fullcan Biotechnology Co., Ltd., Beijing, 100085, China.
- Chifeng Fullcan Biotechnology Co., Ltd., Inner Mongolia, 024099, China.
- Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Zitieren
APA
Li, X., Deng, R., Li, J., Li, H., Xu, Z., Zhang, L., Feng, L., Shu, C., Zhen, M., & Wang, C. (2023). Oral [60]fullerene reduces neuroinflammation to alleviate Parkinson's disease via regulating gut microbiome. Theranostics. https://doi.org/10.7150/thno.85711
Vancouver
Li X, Deng R, Li J, Li H, Xu Z, Zhang L, et al. Oral [60]fullerene reduces neuroinflammation to alleviate Parkinson's disease via regulating gut microbiome. Theranostics. 2023. doi:10.7150/thno.85711
BibTeX
@article{Li2023,
author = {Li, Xue and Deng, Ruijun and Li, Jie and Li, Hui and Xu, Zhe and Zhang, Lei and Feng, Linyin and Shu, Chunying and Zhen, Mingming and Wang, Chunru},
title = {Oral [60]fullerene reduces neuroinflammation to alleviate Parkinson's disease via regulating gut microbiome},
journal = {Theranostics},
year = {2023},
doi = {10.7150/thno.85711}
}
EUVIMED